Contract Development And Manufacturing Organizations (CDMO)

Cerbios Expands HPAI Manufacturing Capacity

Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its building dedicated for high potency active ingredients (HPAIs).

DCAT Week 2019

MENA Pharmaceutical Market

Opportunities for Western CDMOs in China

M&A in Pharma and CRO/CMO Industry

Opposites Attract

If You Want to Go Far, Go Together

Supply Security of Non-cGMP Materials

A Wide Spectrum of Contract Services

Pharma: Adapting to an Ever-Changing Environment

Winning Strategies in the Pharmaceutical CDMO Industry

East or West? East and West!

Cambrex to Acquire Halo Pharma

CatSci Appoints Paul Bradley as Head of Business Development

Celonic: Soenke Brunswieck appointed as Vice President Cell & Gene Therapy

Addressing Challenges in Sterile Manufacturing

Lonza Adds More Building Blocks for the Healthcare Continuum

Bernard Pluta Appointed as President of Recipharm’s Development Services

Lynn Lewis Appointed as SVP of Global Sales at Envigo

Celonic Acquires Glycotope Bio-manufacturing Facility

Both Positive and Negative Effects

CMC Biologics Hikes Capacity in Denmark

Ensuring Better Efficiency and Consistency

Earning a Large Chunk of the Cake

Pharma R&D Productivity Needs Improvement

Confidentiality is a Potential Pitfall

Consolidation is here to Stay

Changes in Portfolios and Pipelines are Likely

Setting High Standards

A Partner to Relieve the Strain

M&A in Pharma and CRO/CMO Industry

Innovative Companies Have to Deal with Risks

The Expanding Role of Contract Manufacturing

Neuland Laboratories Opens Dedicated Process Engineering Lab

Vistin Pharma Sells Opioids/CMO business to TPI Enterprises